SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Baird Medical Investment Holdings Limited (BDMD) has a negative trailing P/E of -15.9, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -6.29%.
Criteria proven by this page:
- VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Trailing Earnings Yield -6.29% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
Overall SharesGrow Score: 80/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BDMD
Valuation Multiples
P/E (TTM)-15.9
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.42
P/S Ratio2.20
EV/EBITDA80.8
Per Share Data
EPS (TTM)$-0.12
Book Value / Share$1.35
Revenue / Share$1.21
FCF / Share$-0.30
Yields & Fair Value
Earnings Yield-6.29%
Dividend Yield0.00%
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-9.7 |
0.00 |
-3.17 |
5.69 |
- |
| 2020 |
9.8 |
-0.05 |
9.64 |
3.84 |
- |
| 2021 |
6.1 |
-0.06 |
13.62 |
2.56 |
7.66% |
| 2022 |
5.1 |
-0.03 |
2.49 |
1.84 |
- |
| 2023 |
7.7 |
0.00 |
2.27 |
2.58 |
- |
| 2024 |
15.6 |
0.80 |
4.90 |
5.24 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$0.00 |
$12.21M |
$-7.18M |
-58.8% |
| 2020 |
$0.00 |
$18.12M |
$7.1M |
39.2% |
| 2021 |
$-0.02 |
$27.72M |
$11.68M |
42.1% |
| 2022 |
$0.02 |
$35.09M |
$12.57M |
35.8% |
| 2023 |
$-0.22 |
$31.46M |
$10.55M |
33.5% |
| 2024 |
$0.49 |
$37.04M |
$12.45M |
33.6% |
